Source: Streetwise Reports 04/19/2023 Phase 3 trials are the last major step in new drug approval and can cost a lot to operate. However,...
Congratulations, you’ve decided to jump in on the psychedelics revolution by starting your own psychedelics company. You’ve got your business plan,...
Source: Streetwise Reports 04/13/2023 Algernon Pharmaceuticals Inc. and its subsidiary Algernon NeuroScience have reached a new milestone...
The company's portfolio includes several late-stage clinical assets. The post Seelos Therapeutics Doses ALS Patients in Federal Program appeared first...
SB 58, legislation which would decriminalize certain psychedelic substances, has been advanced by the California Senate Public Safety Committee despite...
KWC recently closed its clinics due to financial problems. The post Startup Hormonal Wellness Platform to Buy Ketamine Wellness Centers appeared first...
On a warm spring day, March 28, 2023, I found myself once again making the trek to the city of Angels. As part of the Reality...
Filament Health Corp. (OTCQB: FLHLF / NEO: FH / FSE: 7QS), a clinical-stage natural psychedelic drug development company, released its fourth quarter...
The article News You Might Have Missed: April 3rd, 2023 was originally published on Microdose. Welcome to the News You Might Have Missed, a weekly roundup...
Compared to other psychedelic conferences, ECNP was a dose of European realism - from the anticipated effect sizes of psychedelic trials to the cut and...